We are live on ! Find out more
FAS

Formuepleje A/S Portfolio holdings

AUM $1.28B
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+24.24%
3 Year Est. Return
+75.12%
5 Year Est. Return
+78.91%
10 Year Est. Return
+321.64%
AUM
$960M
AUM Growth
+$123M
Cap. Flow
+$77.7M
Cap. Flow %
8.09%
Top 10 Hldgs %
56.68%
Holding
75
New
6
Increased
17
Reduced
34
Closed
5

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.4M
2
NKE icon
Nike
NKE
+$18.1M
3
CHRW icon
C.H. Robinson
CHRW
+$16.2M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$7.87M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$14M
2
MSFT icon
Microsoft
MSFT
+$5.04M
3
UNH icon
UnitedHealth
UNH
+$2.37M
4
TWX
Time Warner Inc
TWX
+$747K
5
PNRA
Panera Bread Co
PNRA
+$456K

Sector Composition

Rank Sector Weight
1 Healthcare 25.57%
2 Financials 23.36%
3 Consumer Discretionary 16.71%
4 Technology 9.92%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCI icon
1
Service Corp International
SCI
$11.4B
$80.1M 8.34%
2,393,950
+62,200
+3% +$1.98M
ELV icon
2
Elevance Health
ELV
$86.6B
$69.8M 7.27%
370,948
+9,100
+3% +$1.64M
MSFT icon
3
Microsoft
MSFT
$3.75T
$64M 6.67%
928,942
-73,400
-7% -$5.04M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$43.8B
$58.1M 6.05%
1,747,500
+659,700
+61% +$20.4M
MCO icon
5
Moody's
MCO
$88.2B
$56M 5.84%
460,470
+12,200
+3% +$1.43M
NKE icon
6
Nike
NKE
$57B
$52.7M 5.49%
893,658
+336,200
+60% +$18.1M
UNH icon
7
UnitedHealth
UNH
$355B
$44.8M 4.67%
241,753
-13,500
-5% -$2.37M
DOV icon
8
Dover
DOV
$27.2B
$43.3M 4.52%
668,867
-3,714
-0.6% -$242K
GILD icon
9
Gilead Sciences
GILD
$185B
$37.7M 3.93%
532,879
+79,400
+18% +$5.28M
V icon
10
Visa
V
$709B
$37.4M 3.9%
398,860
-2,900
-0.7% -$269K
SPGI icon
11
S&P Global
SPGI
$128B
$32.2M 3.36%
220,715
-100,700
-31% -$14M
AXP icon
12
American Express
AXP
$226B
$31.6M 3.29%
374,527
-2,600
-0.7% -$206K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.13T
$28.7M 2.99%
632,000
+172,000
+37% +$7.87M
C icon
14
Citigroup
C
$223B
$27.5M 2.87%
411,690
+20,900
+5% +$1.28M
BIIB icon
15
Biogen
BIIB
$32.7B
$25.3M 2.64%
93,400
+23,200
+33% +$6.13M
WFC icon
16
Wells Fargo
WFC
$257B
$24.9M 2.6%
449,700
-2,600
-0.6% -$139K
SRCL
17
DELISTED
Stericycle Inc
SRCL
$21.7M 2.26%
284,060
-1,600
-0.6% -$131K
INTC icon
18
Intel
INTC
$487B
$18.6M 1.93%
549,800
-2,000
-0.4% -$71.6K
EL icon
19
Estee Lauder
EL
$38.4B
$18.5M 1.93%
192,500
-800
-0.4% -$73.4K
CBRE icon
20
CBRE Group
CBRE
$42.6B
$16.7M 1.74%
+457,800
New +$15.9M
OMC icon
21
Omnicom Group
OMC
$24.1B
$16.5M 1.72%
198,788
-1,600
-0.8% -$133K
CHRW icon
22
C.H. Robinson
CHRW
$17.7B
$15.7M 1.64%
+229,100
New +$16.2M
ALV icon
23
Autoliv
ALV
$9B
$14.7M 1.53%
185,576
-1,388
-0.7% -$105K
SLB icon
24
SLB Ltd
SLB
$81.6B
$14.6M 1.52%
221,175
+82,600
+60% +$5.92M
BLK icon
25
Blackrock
BLK
$181B
$14.5M 1.51%
34,357
-300
-0.9% -$120K

Similar funds

Formuepleje A/S's Q2 2017 Portfolio in Review

As of Q2 2017, Formuepleje A/S held 75 positions worth $960M, up 15% from $837M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Formuepleje A/S deployed $77.7M of net new capital in Q2 2017, opening 6 new positions and adding to 17 existing holdings. Its largest new stake was C.H. Robinson: 229,100 shares worth $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was S&P Global, an estimated $14M trimmed.

  • Formuepleje A/S's largest Q2 2017 buy was C.H. Robinson: 229,100 shares worth $15.7M.
  • Formuepleje A/S added most to Teva Pharmaceuticals in Q2 2017, an estimated $20.4M increase.
  • Formuepleje A/S's biggest Q2 2017 reduction was S&P Global, cutting an estimated $14M.
  • Formuepleje A/S fully exited Time Warner Inc in Q2 2017, selling an estimated $747K.
  • Formuepleje A/S's ten largest holdings make up 57% of its $960M portfolio in Q2 2017.
  • Formuepleje A/S opened 6 new positions and closed 5 in Q2 2017.
  • Formuepleje A/S's portfolio value rose 15% quarter-over-quarter to $960M.

Based on Formuepleje A/S's 13F filing for Q2 2017, filed 27 Aug 2026.